New strategy aims to keep lymphoma at bay after powerful CAR-T treatment
Disease control
Not yet recruiting
This study is looking at whether taking the drug zanubrutinib after receiving CAR-T cell therapy helps keep B-cell lymphoma from coming back. It will involve about 40 adults who have already had or are scheduled to get CAR-T treatment. The main goal is to see if this maintenance …
Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC